Intézmény

Erasmus Hospital

Brussels, BelgiumHonlap

Más néven: Erasmus Ziekenhuis · Hôpital Érasme

150futó vizsgálat
77lezárt vizsgálat
20 076publikáció (OpenAlex)

Futó vizsgálatok

Még nem toboroz
Safety and Efficacy of VX-828/Deutivacaftor Combination Therapy With and Without Tezacaftor in Subjects With Cystic Fibrosis
2025-523400-72-00· 2. fázis· Vertex Pharmaceuticals Inc.· Forrás
Még nem toboroz
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
2026-526404-71-00· 2. fázis· Agomab Spain S.L.U.· Forrás
Még nem toboroz
A study to investigate safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis (stage F4 fibrosis) due to MASH (NEBULA-2)
2026-525757-37-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás
Még nem toboroz
A pivotal clinical study to investigate the safety and efficacy of efimosfermin compared with placebo in adult participants with compensated cirrhosis due to Metabolic dysfunction-associated steatohepatitis (MASH)
2026-525755-82-00· 3. fázis· Glaxosmithkline Research & Development Limited· Forrás
Toboroz
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy (KINSHIP-OLE).
2026-526139-20-00· 3. fázis· Kardigan Inc.· Forrás
Toboroz
ENDO-REAL: Endometriosis and Reproductive Enhancement with Letrozole
2025-524995-53-00· 4. fázis· UZ Brussel· Forrás
Toboroz
ROSY-F: Roll-over Study for Participants Who Have Completed a Previous Clinical Study with Benralizumab (Fasenra) and Benefit from Continued Treatment
2025-523307-29-00· 3. fázis· AstraZeneca AB· Forrás
Toboroz
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07771465· 3. fázis· Kardigan, Inc.· Forrás
Toboroz
A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
NCT07673887· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás
Toboroz
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
NCT07725939· 2. fázis· UCB Biopharma SRL· Forrás
Toboroz
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087· 3. fázis· Boehringer Ingelheim· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
NCT07481981· 3. fázis· Insmed Incorporated· Forrás
Toboroz
A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)
NCT07656415· 3. fázis· Agios Pharmaceuticals, Inc.· Forrás
Toboroz
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
NCT07665437· 3. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
Pridopidine Phase 3 Study in Huntington's Disease
NCT07609108· 3. fázis· Prilenia· Forrás
Toboroz
A Long-Term Extension Study of IMVT-1402 in Adult Patients With Graves' Disease
2025-524001-33-00· 2. fázis· Immunovant Sciences GmbH· Forrás
Toboroz
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
NCT07620392· 2. fázis· Hoffmann-La Roche· Forrás
Toboroz
Crohn’s Head-to-Head Assessing Risankizumab Versus Guselkumab for One Year
2025-521590-13-00· 3. fázis· Janssen Cilag International· Forrás
Toboroz
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07577856· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
NCT07318597· 2. fázis· Regeneron Pharmaceuticals· Forrás
Toboroz
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
NCT07285655· 3. fázis· Liquidia Technologies, Inc.· Forrás
Toboroz
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
NCT07365332· 3. fázis· Inhibikase Therapeutics· Forrás
Toboroz
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
2025-521546-23-00· 3. fázis· Novartis Pharma AG· Forrás
Toboroz
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
NCT07067463· 3. fázis· Zenas BioPharma (USA), LLC· Forrás
Toboroz
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
NCT07351045· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
NCT07456033· 3. fázis· GlaxoSmithKline· Forrás
Toboroz
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
NCT07286058· 3. fázis· Takeda· Forrás
Toboroz
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
NCT07404865· 3. fázis· Vor Biopharma· Forrás
Toboroz
A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy.
2025-522553-19-00· 2/3. fázis· Kardigan Inc.· Forrás
Toboroz
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
NCT07339423· 3. fázis· Novo Nordisk A/S· Forrás
Toboroz
A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis
NCT07298044· 4. fázis· Bayer· Forrás
Toboroz
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07210723· 2/3. fázis· Kardigan, Inc.· Forrás
Toboroz
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
NCT07392190· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
NCT07222332· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
Effect of Anti-Psoriatic Biologics on Risk of Anogenital Warts (CONDYPSO)
NCT07234838· Jonathan Krygier· Forrás
Toboroz
The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension
NCT07359599· 4. fázis· Ziekenhuis Oost-Limburg· Forrás
Toboroz
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
NCT07225569· 2. fázis· Sanofi· Forrás
Toboroz
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
NCT07221188· 3. fázis· GlaxoSmithKline· Forrás
Meghívásos bevonás
Characterisation of a Population of Adults Suffering From Cystic Fibrosis in a Belgian Reference Center
NCT07442682· Erasme University Hospital· Forrás
Toboroz
A Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have not Responded to or who Cannot Tolerate TNF and/or JAK Inhibitors
2025-521034-28-00· 2. fázis· F. Hoffmann-La Roche AG· Forrás
Toboroz
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
NCT07221253· 3. fázis· AstraZeneca· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
NCT06804811· 3. fázis· Incyte Corporation· Forrás
Toboroz
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
NCT07165028· 3. fázis· Eli Lilly and Company· Forrás
Fut, nem toboroz
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME-CV)
2024-516652-18-00· 3. fázis· Amgen Inc.· Forrás
Meghívásos bevonás
Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease
NCT07548801· Université Libre de Bruxelles· Forrás
Toboroz
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
NCT06919965· 3. fázis· Janssen Research & Development, LLC· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
2024-517529-26-00· 3. fázis· Dianthus Therapeutics Inc.· Forrás
Toboroz
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT07064473· 3. fázis· Boehringer Ingelheim· Forrás
Toboroz
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
NCT06937086· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
NCT06937099· 3. fázis· Eli Lilly and Company· Forrás

Showing 50 of 150.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

Crohn-betegség10 toboroz
Zsírmáj (MASLD/MASH)9 toboroz
Magas vérnyomás6 toboroz
Máj- és epeúti rák5 toboroz
Pulmonális artériás hipertónia5 toboroz
Dilated cardiomyopathy4 toboroz
Colitis ulcerosa3 toboroz
Elhízás3 toboroz
Hidradenitis suppurativa3 toboroz
Pikkelysömör3 toboroz
Sarlósejtes vérszegénység3 toboroz
2-es típusú cukorbetegség2 toboroz
Amiloidózis2 toboroz
Asztma2 toboroz
Cisztás fibrózis2 toboroz
Graves' disease and hyperthyroidism2 toboroz
Gyomor- és nyelőcsőrák2 toboroz
Hasnyálmirigyrák2 toboroz
Idiopátiás tüdőfibrózis2 toboroz
Liver cirrhosis2 toboroz
Rheumatoid arthritis2 toboroz
Sclerosis multiplex (SM)2 toboroz
1-es típusú cukorbetegség1 toboroz
ANCA-asszociált vasculitis1 toboroz
Aortic aneurysm1 toboroz
Aortic stenosis1 toboroz
Arthritis psoriatica1 toboroz
Endometriózis1 toboroz
Epilepszia1 toboroz
Friedreich-ataxia1 toboroz
Hólyagrák1 toboroz
Huntington-kór1 toboroz
IgA-nefropátia1 toboroz
Krónikus gyulladásos demielinizációs polineuropátia (CIDP)1 toboroz
Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
Lupus (SLE)1 toboroz
Myasthenia gravis1 toboroz
Parkinson-kór1 toboroz
Sjögren-szindróma1 toboroz
Szisztémás szklerózis (szkleroderma)1 toboroz
Thalassaemia1 toboroz
Vastagbélrák1 toboroz
Vitiligo1 toboroz

Lezárt vizsgálatok

Lezárult
An Open-Label Extension Study for Participants with PAH Who Have Previously Participated in a Clinical Trial with PF-07868489
2025-521155-23-00· 2. fázis· Pfizer Inc.· Forrás
Leállították
A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy
NCT06987968· 2. fázis· Genfit· Forrás
Lezárult
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
NCT06926660· 2. fázis· Boehringer Ingelheim· Forrás
Toboroz
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
NCT06699849· 2. fázis· CSL Behring· Forrás
Lezárult
A Study of the Efficacy and Safety of Efgartigimod in Patients with Primary Sjögren's Syndrome (pSjD) (UNITY)
NCT06684847· 3. fázis· Argenx· Forrás
Lezárult
A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Belgium
NCT06677892· Takeda· Forrás
Fut, nem toboroz
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884· 2. fázis· Endeavor Biomedicines, Inc.· Forrás
Lezárult
A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-Severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and an Open- labeled Long-term Extension Treatment with Aticaprant
2024-511557-21-00· 3. fázis· Janssen Cilag International· Forrás
Lezárult
A Phase 2 Dose-Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejection Fraction
2023-508736-62-00· 2. fázis· Cardurion Pharmaceuticals Inc.· Forrás
Lezárult
A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis
NCT06238817· 3. fázis· Incyte Corporation· Forrás
Lezárult
A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects with Moderate to Severe Rheumatoid Arthritis
2023-504564-42-00· 2. fázis· Anaptysbio Inc.· Forrás
Fut, nem toboroz
A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis
NCT06257875· 2. fázis· AbbVie· Forrás
Fut, nem toboroz
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT06212999· 3. fázis· Incyte Corporation· Forrás
Lezárult
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
NCT05934526· 3. fázis· GB002, Inc.· Forrás
Lezárult
Probiotics to Actively Counter Ventilator Associated Pneumonia (PROACT)
NCT06092554· University of Bari· Forrás
Lezárult
A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight
NCT06066515· 3. fázis· Boehringer Ingelheim· Forrás
Lezárult
Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy
2022-502316-36-00· 4. fázis· Myokardia Inc.· Forrás
Lezárult
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
NCT06137742· 1/2. fázis· Pfizer· Forrás
Leállították
A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382
NCT06032546· 2. fázis· AbbVie· Forrás
Lezárult
Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations
NCT06040086· 3. fázis· AstraZeneca· Forrás
Lezárult
Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial – Follow Up Long Term Extension (IMPAHCT-FUL)
NCT05557942· 3. fázis· Aerovate Therapeutics Inc.· Forrás
Fut, nem toboroz
An early access study of ivosidenib in patients with a pretreated locally advanced or metastatic cholangiocarcinoma
2022-501463-40-01· 3. fázis· Servier Affaires Medicales· Forrás
Lezárult
A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe AD (ROCKET-Horizon)
2022-501538-44-00· 3. fázis· Amgen Inc.· Forrás
Lezárult
A Study to Evaluate Rocatinlimab (AMG 451) in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
NCT05704738· 3. fázis· Amgen· Forrás
Lezárult
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy
NCT05582395· 3. fázis· Myokardia Inc.· Forrás
Fut, nem toboroz
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
NCT05785611· 3. fázis· Alfasigma S.p.A.· Forrás
Lezárult
A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke
NCT05686070· 3. fázis· Bayer· Forrás
Lezárult
ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA
NCT05992142· 4. fázis· Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW· Forrás
Lezárult
Phase 2b Study of GSK4532990 in Adults With NASH
NCT05583344· 2. fázis· GlaxoSmithKline· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa
NCT05620823· 3. fázis· Incyte Corporation· Forrás
Lezárult
A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)
NCT05651711· 3. fázis· Amgen· Forrás
Lezárult
A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms
NCT05559580· 2. fázis· Boehringer Ingelheim· Forrás
Lezárult
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
NCT05507203· 3. fázis· Abivax S.A.· Forrás
Fut, nem toboroz
A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease
NCT05347095· 3. fázis· Janssen-Cilag Ltd.· Forrás
Lezárult
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension
NCT05147805· 2. fázis· Insmed Incorporated· Forrás
Fut, nem toboroz
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
NCT05263934· 3. fázis· GlaxoSmithKline· Forrás
Lezárult
Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial (IMPAHCT) or A Phase 2b/3, Randomized, Controlled, 24-week Dose Ranging and Confirmatory Study of AV-101 in Patients with PAH
NCT05036135· 2/3. fázis· Aerovate Therapeutics Inc.· Forrás
Lezárult
A Phase 3 Study of Sotatercept in Newly Diagnosed Intermediate- and High-risk Pulmonary Arterial Hypertension (PAH) Patients.
NCT04811092· 3. fázis· Acceleron Pharma Inc.· Forrás
Lezárult
Chemical and Mechanical Angioplasty for Vasospasm (SAVEBRAIN)
NCT05268445· Erasme University Hospital· Forrás
Lezárult
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
NCT05014672· 2. fázis· Calliditas Therapeutics Suisse SA· Forrás
Lezárult
A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16)
NCT04945460· 2. fázis· Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA· Forrás
Lezárult
A Study of Sotatercept in Participants With PAH WHO FC III or FC IV at High Risk of Mortality (MK-7962-006/ZENITH)
NCT04896008· 3. fázis· Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA· Forrás
Lezárult
An open-label phase 1b/2 study assessing the safety and efficacy of mitazalimab in combination with chemotherapy in patients with metastatic pancreatic ductal adenocarcinoma
2024-514905-79-00· 1/2. fázis· Alligator Bioscience AB· Forrás
Lezárult
A Long-term Follow-up Study of Sotatercept for PAH Treatment
NCT04796337· 3. fázis· Acceleron Pharma Inc.· Forrás
Lezárult
A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)
NCT04732221· 2/3. fázis· Merck Sharp & Dohme LLC· Forrás
Lezárult
Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type.
NCT04464564· 3. fázis· Otsuka Pharmaceutical Development & Commercialization Inc.· Forrás
Lezárult
A Study of Atezolizumab with Lenvatinib or Sorafenib versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated with Atezolizumab and Bevacizumab
2023-503229-21-00· 3. fázis· F. Hoffmann-La Roche AG· Forrás
Lezárult
Verapamil SR in Adults With Type 1 Diabetes
NCT04545151· 2. fázis· Medical University of Graz· Forrás
Lezárult
Validation of Kinocardiography, a New Technology Measuring Cardiac Mechanical Activity Via Accelerometers and Gyroscopes
NCT04772807· Erasme University Hospital· Forrás
Lezárult
A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
NCT04704154· 2. fázis· Bayer· Forrás

Showing 50 of 77.

Regiszterbeli névváltozatok (25)

A vizsgálati regiszterek ezeken a neveken tartják nyilván az intézményt. Minden sor egy regiszterbejegyzés: a címe és az alatta nyilvántartott vizsgálatok.

Hopital Erasme
Anderlecht, 1070
176 vizsgálat
Hôpital Erasme
Brussels, Brussels Capital 1070
18 vizsgálat
Erasme Hospital
Brussels, 1070
7 vizsgálat
Université Libre de Bruxelles - Hôpital Erasme
Brussels, Bruxelles-capitale, Région de 1070
7 vizsgálat
Hospital Erasme
Brussels, 1070
4 vizsgálat
Hôpital Erasme/Erasmus Ziekenhuis
Brussels, 1070
2 vizsgálat
- NCT07298044A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloidosis With Cardiomyopathy Switch From Tafamidis to Acoramidis
- NCT04704154A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
Université Libre de Bruxelles, Hôpital Erasme, Dpt of Neurology
Brussels, 1070
2 vizsgálat
- NCT06016946Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
  Contact: Fabienne Deveylder
- NCT02069509Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)
Universite Libre de Bruxelles (ULB) - Hopital Erasme
Brussels, 1070
2 vizsgálat
- NCT07771465A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
  Contact: Kardigan Clinical Trial Team
- NCT07210723A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
  Contact: Kardigan Clinical Trial Team
Erasme Hospital (Site 0204)
Brussels, Bruxelles-Capitale, Region de 1070
1 vizsgálat
- NCT04003636Pembrolizumab (MK-3475) Plus Gemcitabine/Cisplatin Versus Placebo Plus Gemcitabine/Cisplatin for First-Line Advanced and/or Unresectable Biliary Tract Carcinoma (BTC) (MK-3475-966/KEYNOTE-966)
Erasme Hospital (Site 0376)
Brussels, Bruxelles-Capitale, Region de 1070
1 vizsgálat
- NCT03867084Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
Erasmus Hospital
Anderlecht, Brussels Capital 1070
1 vizsgálat
- NCT07717437DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
  Contact: Valerio Lucidi, Dr.
Erasmus Hospital
Brussels, Brussels Capital 1070
1 vizsgálat
- NCT06914648The Dragon PLC Trial (DRAGON-PLC)
  Contact: Valerio Lucidi, Dr. (principal investigator)
Erasmus ziekenhuis
Brussels, Brussels Capital 1070
1 vizsgálat
- NCT05169593Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
  Contact: Denis Franchimont, MD
Hôpital Erasme
Liège
1 vizsgálat
- NCT04114825Study of RV001V in Biochemical Failure Following Curatively Intended Therapy For Localized Prostate Cancer
Hôpital Erasme - HUB 808 route de Lennik 1070 Brussels Belgium
Brussels, 1070
1 vizsgálat
- NCT07442682Characterisation of a Population of Adults Suffering From Cystic Fibrosis in a Belgian Reference Center
H.U.B. - Hôpital Erasme
Brussels
1 vizsgálat
- NCT07363044A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease
  Contact: Denis Franchimont, Dr
Université Libre de Bruxelles - Hôpital Erasme
Brussels, Bruxelles-Capitale, 1070
1 vizsgálat
- NCT07392190A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Université Libre de Bruxelles - Hôpital Erasme (Site 0100)
Brussels, Bruxelles-Capitale, Region de 1070
1 vizsgálat
- NCT06814145Extension Study of Sotatercept in People With Pulmonary Hypertension (MK-7962-023)
Université Libre de Bruxelles - Hôpital Erasme - ULB
Brussels
1 vizsgálat
- NCT04524949IMCY-0098 Proof of ACtion in Type 1 Diabetes (IMPACT Study)
Hopital Erasme
Brussel (Bruxelles), 1070
Hopital Erasme, HUB
Brussels, 1070
Hopital Erasme - Site #402
Brussels, 1070
Université Libre de Bruxelles - Hôpital Erasme (Site 0601)
Brussels, Bruxelles-Capitale, Region de 1070
Université Libre de Bruxelles - Hôpital Erasme (Site 1302)
Brussels, Bruxelles-Capitale, Region de 1070
Université Libre de Bruxelles - Hôpital Erasme (Site 1402)
Brussels, Bruxelles-Capitale, Region de 1070

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

Pulmonális artériás hipertónia12 munka · 23 vizsgálat
Hidradenitis suppurativa12 munka · 11 vizsgálat
Friedreich-ataxia3 munka · 2 vizsgálat

Intézményadatok: ROR 05j1gs298 (CC0-1.0)Frissítve: 2026. nov. 12.

Hibát jelzek